| Dr Raymond Jackson Harshbarger Iii, MD | |
|
1301 Barbara Jordan Blvd Ste 307, Austin, TX 78723-3080 | |
| (512) 324-0919 | |
| Not Available |
| Full Name | Dr Raymond Jackson Harshbarger Iii |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 30 Years |
| Location | 1301 Barbara Jordan Blvd Ste 307, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124145255 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Seton Medical Center Williamson | Round rock, TX | Hospital |
| Dell Seton Med Center At The University Of Tx | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Family Of Doctors | 0941333280 | 663 |
News Archive
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Zymo Research announced today that it is offering five new sample collection devices. Each type of collection tube contains Zymo Research's DNA/RNA Shield™ storage reagent, which preserves the genetic integrity and expression profiles of various samples such as cells, tissues, blood, plasma, serum, saliva, urine, and feces, at ambient temperatures for extended periods.
Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.
Aestus Therapeutics, Inc. announced today a collaboration agreement with Eisai Inc. on research and development of novel therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies.
› Verified 9 days ago
| Entity Name | Dell Childrens Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326072943 PECOS PAC ID: 8224092978 Enrollment ID: O20041112001030 |
News Archive
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Zymo Research announced today that it is offering five new sample collection devices. Each type of collection tube contains Zymo Research's DNA/RNA Shield™ storage reagent, which preserves the genetic integrity and expression profiles of various samples such as cells, tissues, blood, plasma, serum, saliva, urine, and feces, at ambient temperatures for extended periods.
Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.
Aestus Therapeutics, Inc. announced today a collaboration agreement with Eisai Inc. on research and development of novel therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies.
› Verified 9 days ago
| Entity Name | Seton Family Of Doctors |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588997233 PECOS PAC ID: 0941333280 Enrollment ID: O20100806000260 |
News Archive
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Zymo Research announced today that it is offering five new sample collection devices. Each type of collection tube contains Zymo Research's DNA/RNA Shield™ storage reagent, which preserves the genetic integrity and expression profiles of various samples such as cells, tissues, blood, plasma, serum, saliva, urine, and feces, at ambient temperatures for extended periods.
Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.
Aestus Therapeutics, Inc. announced today a collaboration agreement with Eisai Inc. on research and development of novel therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond Jackson Harshbarger Iii, MD 1301 Barbara Jordan Blvd Ste 307, Austin, TX 78723-3080 Ph: (512) 324-0919 | Dr Raymond Jackson Harshbarger Iii, MD 1301 Barbara Jordan Blvd Ste 307, Austin, TX 78723-3080 Ph: (512) 324-0919 |
News Archive
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Zymo Research announced today that it is offering five new sample collection devices. Each type of collection tube contains Zymo Research's DNA/RNA Shield™ storage reagent, which preserves the genetic integrity and expression profiles of various samples such as cells, tissues, blood, plasma, serum, saliva, urine, and feces, at ambient temperatures for extended periods.
Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.
Aestus Therapeutics, Inc. announced today a collaboration agreement with Eisai Inc. on research and development of novel therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies.
› Verified 9 days ago
Sally Matika, PA-C Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6818 Austin Center Blvd Ste 204, Austin, TX 78731 Phone: 512-867-6211 | |
Mr. James Thomas Robison Iv, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Cave Rd, Suite J-200, Austin, TX 78746 Phone: 512-450-1077 Fax: 512-450-1817 | |
Kelly Eugene Tjelmeland, M D Plastic Surgery Medicare: Medicare Enrolled Practice Location: 4220 Bull Creek Rd, Austin, TX 78731 Phone: 512-617-7500 | |
E Richard Parker, M. D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4220 Bull Creek Rd, Austin, TX 78731 Phone: 512-617-7500 | |
Dr. Sanjay Kumar Sharma, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 N Ih 35, Suite 320, Austin, TX 78701 Phone: 512-324-8320 Fax: 512-324-8323 | |
Dr. Dustin Leon Reid, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 901 W 38th St, Suite 401, Austin, TX 78705 Phone: 512-371-8817 Fax: 512-371-8819 | |
Dr. David Brian Dellinger, DO Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11623 Angus Rd, Suite C15, Austin, TX 78759 Phone: 512-229-1978 Fax: 512-229-1978 |